Comprehensive Clinical Laboratory Testing and On-Site Specimen Collection Services

Location:	Texas
Posted:	Jul 17, 2026
Due:	Aug 7, 2026
Agency:	State Government of Texas
Type of Government:	State & Local
Category:	Q - Medical Services
Solicitation No:	IC-RFP-2026-003
Publication URL:	To access bid details, please log in.

Follow Solicitation

Solicitation ID:

IC-RFP-2026-003

Status:

Posted

Contact Name:

Christina Lundy

Contact Number:

(737) 424-4349

Contact Email:

Christina.lundy@integralcare.org

Bid Response Email:

procurement@integralcare.org

Response Due Date:

8/7/2026

Response Due Time:

5:00 PM

Agency/Texas SmartBuy Member Number:

R2270

Posting Requirement:

21+ Days for Solicitation Notice

State Agency Procurement Certification:

Dual CTCD/CTCM certification

Solicitation Posting Date:

7/17/2026

Last Modified:

7/17/2026 5:46 pm

Class/Item Code:

94855-Medical And Laboratory Services (Non-Physician);

Highway Districts:

District 1,

District 2,

District 3,

District 4,

District 5,

District 6,

District 7,

District 8,

District 9,

District 10,

District 11,

District 12,

District 13,

District 14,

District 15,

District 16,

District 17,

District 18,

District 19,

District 20,

District 21,

District 22,

District 23,

District 24,

District 25

View Highway Districts

Solicitation Description:

Integral Care is seeking proposals from qualified clinical laboratory service providers to deliver comprehensive laboratory testing and on-site specimen collection services supporting individuals receiving behavioral health and related community-based services.

The selected provider will furnish timely and reliable routine, specialized, and expedited laboratory services to support diagnostic evaluation, medication management, metabolic monitoring, crisis stabilization, substance use treatment, and ongoing clinical decision-making. Anticipated services include blood panels, hematology, endocrine testing, urinalysis, toxicology and drug screening, therapeutic drug monitoring, infectious disease testing, STI screening, HIV and hepatitis screening, tuberculosis testing, and other medically necessary clinical laboratory diagnostics.

Proposers should demonstrate the operational capacity to support high-volume testing, including CBC, A1C, lipid panels, comprehensive metabolic panels, thyroid testing, therapeutic drug monitoring, urine toxicology, and infectious disease screening. Proposers must also describe available STAT, rapid, or other expedited testing options and applicable turnaround times. Questions Due: Monday, July 27, 2026. Proposal Deadline: Friday, August 7, 2026, at 5:00 p.m. Central Daylight Time

Comprehensive Clinical Laboratory Testing and On-Site Specimen Collection Services

See also